Orphan drug designation will entitle PAT-SM6 to ten years of market exclusivity for multiple myeloma; scientific advice and protocol assistance by the EMA to optimise drug development; regulatory assistance and facilitated access to the Centralised Procedure for marketing approval; numerous financial incentives and fee reductions for regulatory activities; and access to grant funding schemes. - See more at: http://www.biospectrumasia.com/biospectrum/news/195347/ema-patrys-cancer-drug-orphan-status#.UjrWhIYbDTp
ahpigsy i seriously dont think te market has factored this news in yet and what its worth is to pab
malmanu i love this quote from Stuart Roberts a man who knows his bios
Is there an Australian angle to this story? If you go to the web site for the ASX-listed cancer antibody developer Patrys you can find some research there suggesting that the cancer antibody field has plenty of room for other companies to create serious shareholder value. Worth doing some homework on.
http://ozbiobuzz.blogspot.com.au/2013/08/hello-and-welcome-to-australian.html
- Forums
- ASX - By Stock
- PAB
- pat-sm6 receives orphan drug designationfor mm
pat-sm6 receives orphan drug designationfor mm, page-60
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 1853666 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 3325244 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 1853666 | 0.006 |
16 | 8715158 | 0.005 |
11 | 6064000 | 0.004 |
13 | 6400516 | 0.003 |
5 | 2522000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 3325244 | 5 |
0.008 | 2781393 | 7 |
0.009 | 1080000 | 2 |
0.010 | 396000 | 5 |
0.011 | 1000000 | 1 |
Last trade - 16.12pm 16/08/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
Day chart unavailable